TFFP TFF Pharmaceuticals, Inc.

TFF Pharmaceuticals, Inc. operates as an early-stage biopharmaceutical company. It develops and commercializes drug products based on its Thin film Freezing (TFF) technology platform. The firm also engages in research, development & drug formulation and initial testing of drug products. The company was founded in 2005 and is headquartered in Toronto, Canada.

As of 07/01/2022     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  10/25/2019
Outstanding shares:  25,373,818
Average volume:  61,554
Market cap:   $146,153,192
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BKTN054
Valuation   (See tab for details)
PE ratio:   -2.94
PB ratio:   4.54
PS ratio:   0.00
Return on equity:   -41.38%
Net income %:   -19,372.26%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy